Switglim M 4/500 Sustained Release Diabetes Tablets 15

AboutSwitglim M 4/500 is a prescription combination of Glimepiride and Metformin for Type 2 diabetes. It is used when combination therapy is prescribed along with diet, exercise and glucose monitoring.Usage InstructionsTake with food at the prescribed time. Swallow the tablet whole with water. Do not crush, chew or alter the sustained-release tablet unless instructed. Do not skip meals.BenefitsHelps lower blood glucose by increasing insulin availability and improving the body’s response to insulin.How it WorksGlimepiride increases pancreatic insulin secretion. Metformin reduces hepatic glucose production and improves peripheral insulin sensitivity.Side EffectsHypoglycaemia, nausea, diarrhoea, stomach upset, headache, weakness and metallic taste may occur. Seek immediate help for severe low blood sugar, fainting or breathing difficulty.Safety AdvicePrescription use only. Inform the doctor about kidney or liver disease, heart failure, dehydration, alcohol intake, pregnancy and breastfeeding. Extra monitoring may be needed because the higher Glimepiride strength can increase hypoglycaemia risk.StorageStore below 30°C in a dry place away from heat, sunlight and moisture. Keep out of reach of children.